Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
3
×
gene editing
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
congress
crispr
fda
gilead sciences
glaxosmithkline
hiv
indiana blog main
indiana top stories
vertex pharmaceuticals
abbvie
advaxis
aimmune therapeutics
alder biopharmaceuticals
What
bio
roundup
3
×
ceo
crispr
moves
week
acquisitions
big
biggest
biopharma
bosley's
bosley’s
bridge
bucks
build
buy
cas
company’s
congress
congressional
crime
daniel
debut
departure
drug
dyne’s
editas
executives
exit
feud
gilead
group
guiding
isn’t
katrine
known
later
medicine
microbiome
month
Language
unset
Current search:
roundup
×
" eli lilly "
×
" gene editing "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More